Larsen Benjamin Endré, Bjørnstad Jorunn, Pettersen Erik Olai, Tønnesen Hanne Hjorth, Melvik Jan Egil
School of Pharmacy, University of Oslo, Oslo, Norway.
FMC Biopolymer AS, Sandvika, Norway.
BMC Biotechnol. 2015 May 6;15:29. doi: 10.1186/s12896-015-0147-7.
This work investigates a general method for producing alginate gel matrices using an internal mode of gelation that depends solely on soluble alginate and alginate/gelling ion particles. The method involves the formulation of two-component kits comprised of soluble alginate and insoluble alginate/gelling ion particles. Gelling kinetics, elastic and Young's moduli were investigated for selected parameters with regard to soluble alginate guluronate content, molecular weight, calcium or strontium gelling ions and alginate gelling ion particle sizes in the range between 25 and 125 micrometers.
By mixing the two components and varying the parameters mentioned above, alginate gel matrices with tailor-made viscoelastic properties and gelling kinetics were obtained. Final gel elasticity depended on alginate type, concentration and gelling ion. The gelling rate could be manipulated, e.g. through selection of the alginate type and molecular weight, particle sizes and the concentration of non-gelling ions.
Formulations of the injectable and moldable alginate system presented have recently been used within specific medical applications and may have potential within regenerative medicine or other fields.
本研究探索了一种利用内部凝胶化模式制备藻酸盐凝胶基质的通用方法,该方法仅依赖于可溶性藻酸盐和藻酸盐/凝胶离子颗粒。该方法包括配制由可溶性藻酸盐和不溶性藻酸盐/凝胶离子颗粒组成的双组分试剂盒。针对可溶性藻酸盐古洛糖醛酸含量、分子量、钙或锶凝胶离子以及25至125微米范围内的藻酸盐凝胶离子颗粒尺寸等选定参数,研究了凝胶动力学、弹性和杨氏模量。
通过混合两种组分并改变上述参数,获得了具有定制粘弹性特性和凝胶动力学的藻酸盐凝胶基质。最终凝胶弹性取决于藻酸盐类型、浓度和凝胶离子。凝胶速率可以控制,例如通过选择藻酸盐类型和分子量、颗粒尺寸以及非凝胶离子的浓度。
所展示的可注射和可成型藻酸盐系统配方最近已用于特定医疗应用中,并且在再生医学或其他领域可能具有潜力。